Clinical Trial Update: Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating a combination of palmitoleic acid with infliximab to promote intestinal mucosal healing in Crohn's disease, but recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)
• Palmitoleic Acid (palmitoleic acid)

Snippet

Sponsor: Chinese Medical Association | Conditions: Crohn's Disease | Phase 4 | Status: NOT_YET_RECRUITING